At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 463 enrolled
Drug / intervention
Gold tip catheter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AURUM 8 - Ablation of the Cavotricuspid Isthmus in Patients With Atrial Flutter Using an 8 mm Gold Alloy Tip Electrode
In Brief
A Phase 4 clinical trial evaluating Gold tip catheter and Platinum-iridium tip catheter for Atrial Flutter. Completed, enrolled 463 participants across 28 sites in 3 countries.
Detailed Summary
The purpose of this study is to demonstrate the advantage of using a gold alloy tip electrode over a platinum/iridium alloy tip electrode in ablation of the cavotricuspid isthmus in patients with atrial flutter.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Flutter
CountriesCzechia, Germany, Hungary
Collaborators--
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2004
First PostedMay 2006
Primary CompletionMar 2008
TodayJul 2026
First PostedMay 16, 2006
Enrollment StartJun 1, 2004
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 20.1 years ago
Interventions
Gold tip catheterdevice
Radiofrquency ablation using gold tip catheter
Platinum-iridium tip catheterdevice
Radiofrequency ablation using platinum-iridium tip catheter